Authorization

CytoSorbents to Report Q3 2020 Operating and Financial Results

MONMOUTH JUNCTION, N.J., Oct. 21, 2020 /PRNewswire/ --A CytoSorbents CorporationA (CTSO), a critical care immunotherapy leader commercializing itsA CytoSorbA®A blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,A will report Q3 2020 financial results after the market close on Wednesday, November 4, 2020.A  CytoSorbents' management will host a live conference call and presentation webcast that will recount both operational and financial progress during Q3 2020 followed by a question and answer session.
CytoSorbents to Report Q3 2020 Operating and Financial Results
Conference Call Details:
Date: Wednesday, November 4, 2020
Time: 4:45 PM Eastern
Participant Dial-In:A  877-451-6152
Conference ID:A  13711756
Live Presentation Webcast:A  https://public.viavid.com/index.php?id=141897It is recommended that participants dial in approximately 10 minutes prior to the start of the call.A  There will also be a simultaneous live webcast of the conference call that can be accessed through the following audio feed link:A  https://public.viavid.com/index.php?id=141897An archived recording of the conference call will be available under the Investor Relations section of the Company's website at https://cytosorbents.com/investor-relations/financial-results/A 
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Ноябрь 2020    »
ПнВтСрЧтПтСбВс
 1
2345678
9101112131415
16171819202122
23242526272829
30